BioVid announces Mimetics synthetic physician research
BioVid announced Mimetics in a release dated 22 October 2026. The offering uses synthetic physician audiences for pharmaceutical message and concept testing, positioning, segmentation and opportunity assessment. BioVid says the models draw on its MindSet Modeling physician surveys and secondary information about clinical practice. Clients can commission studies using mimetic respondents alone or alongside people, use an app to question modeled segments, or tailor models with their own research. Managed fieldwork is described as taking one to two weeks after the required inputs arrive, followed by a report and research-team readout. BioVid reports an 80–90% match between mimetic and human cohorts across content, reasoning and emotion, but the announcement does not give the complete scoring protocol or test datasets. A public study price is not listed. The web page carries a 21 October date, while the release itself is dated 22 October.